Literature DB >> 12199816

Helicobacter pylori infection and idiopathic thrombocytopenic purpura.

Giovanni Emilia, Mario Luppi, Monica Morselli, Leonardo Potenza, Nicola D'Apollo, Giuseppe Torelli.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12199816     DOI： 10.1046/j.1365-2141.2002.363010.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.

Authors:  Kingo Fujimura; Masataka Kuwana; Yoshiyuki Kurata; Masahiro Imamura; Hiroshi Harada; Hisashi Sakamaki; Masanao Teramura; Kyuhei Koda; Shosaku Nomura; Sayaka Sugihara; Takeshi Shimomura; Tetsuro-Takahiro Fujimoto; Kazuma Oyashiki; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 2.  Helicobacter pylori infection and idiopathic thrombocytopenic purpura.

Authors:  Kingo Fujimura
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 3.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.

Authors:  Shannon C Jackson; Paul Beck; Andre G Buret; Pamela M O'Connor; Jonathan Meddings; Graham Pineo; Man-Chiu Poon
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

5.  Regression of idiopathic thrombocytopenic purpura after endoscopic mucosal resection of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  M Noda; N Mori; K Nomura; K Kojima; S Mitsufuji; I Yamane; S Misawa; T Okanoue
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

6.  Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  Moo-Kon Song; Joo-Seop Chung; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.